Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach JD Supra 6h
IPO Ahead! Electrical products maker Biocon Electric files draft papers with Sebi The Times of India 4d
USPTO Director Issues Opinion Explaining Denial of Biocon Post-Grant Review Petition (PGR) Challenging EYLEA® Patent JD Supra 7d
Squires Says Biocon Challenge To Eylea Patent Filed Too Late Law360 23:47 Fri, 25 Sep Article paywall
Hlb says bile duct cancer drug lirafugratinib enters full review for European approval Asia Today 2d All sources
Biocon’s pertuzumab biosimilar receives positive CHMP opinion under EMA’s tailored clinical approach JD Supra 6h Pertuzumab Biocon EMA All sources
Ultragenyx's mps iiia gene therapy application validated by EMA RTT News 7d EMA Biology Biotechnology
Sanofi and Regeneron expand immunology partnership to the tune of $8bn Pharmaceutical Technology 8d Sanofi All sources
Uspto director issues opinion explaining denial of Biocon post-grant review petition (PGR) challenging eylea® patent JD Supra 7d Biocon
Regeneron Eylea feels the pinch as Kodiak advances extended dosing for eye drug Benzinga 16:18 Mon, 28 Sep Kodiak Article paywall All sources
